scispace - formally typeset
G

Gideon Koren

Researcher at Ariel University

Publications -  2007
Citations -  88165

Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.

Papers
More filters
Journal ArticleDOI

Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.

TL;DR: Paroxetine does not appear to be associated with an increased risk of cardiovascular defects following use in early pregnancy, as the incidence in more than 3,000 infants was well within the population incidence of approximately 1%.
Journal ArticleDOI

Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making.

TL;DR: Women continue to fear taking antidepressants during pregnancy, more so than non psychiatric drugs, however, evidence based counseling can lower this fear, although not totally.
Journal Article

Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis

TL;DR: Global rates of NVP as reported in the literature using meta-analysis, finding that almost 70% of women worldwide experience NVP, but reported rates vary widely.
Journal ArticleDOI

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.

TL;DR: Factors other than antidepressant exposure during pregnancy strongly predict children's intellect and behavior, and children of depressed mothers may be at risk of future psychopathology.
Journal ArticleDOI

Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study.

TL;DR: Occupational exposure to organic solvents during pregnancy is associated with an increased risk of major fetal malformations, and this risk appears to be increased among women who report symptoms associated with organic solvent exposure.